---
created: 2025-04-13
updated: 2025-04-13T10:53
id: qg54GA{7&K
specialty: immuno
specialty_id: 163
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::rituximab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::23-rituximab
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::23-rituximab::rituximab
  - "source/ak-step1-v11:": 
  - theme/ome::07-immunology::16-immunosuppression
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology::16-immunosuppression
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::04-b-&-t-cells::03-b-cells---overview
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::rituximab
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::03-kinase-inhibitors-&-monoclonal-antibodies::02-rituximab,-cetuximab,-bevacizumab,-alemtuzumab,-trastuzumab
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::20000-20999::20781"
type: flashcard
---

# Question
Rituximab binds CD20 of B-cells and tags it for NK natural killer cells via Ab-**dependent**

---

# Answer
The efficacy of monoclonal antibody therapy is thought to be largely mediated by natural killer NK-cell antibody-dependent cellular cytotoxicity (ADCC)